{"data":{"id":"us/21-cfr-822.25","jurisdiction":"us","citation":"21 CFR 822.25","heading":"What are my responsibilities after my postmarket surveillance plan has been approved?","body":"After we have approved your plan, you must conduct the postmarket surveillance of your device in accordance with your approved plan. This means that you must ensure that:\n(a) Postmarket surveillance is initiated in a timely manner;\n(b) The surveillance is conducted with due diligence;\n(c) The data identified in the plan is collected;\n(d) Any reports required as part of your approved plan are submitted to us in a timely manner; and\n(e) Any information that we request prior to your submission of a report or in response to our review of a report is provided in a timely manner.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER H—MEDICAL DEVICES","PART 822—POSTMARKET SURVEILLANCE","Subpart E—Responsibilities of Manufacturers"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"536b0a2789c08afa0205564ebf17f07cccbe9543f70b494817db3205f1b49d3f","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-822.24","next":"us/21-cfr-822.26"},"notice":"GroundRules: Original legal text. Not legal advice."}
